Shoaib Khan

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 26

Top Topics

Molecular Docking

Structure Activity Relationship

Top Venues

Molecules (Basel, Switzerland)

Pharmaceuticals (Basel, Switzerland)

Zeitschrift fur Naturforschung. C, Journal of biosciences

This page only lists publications with an associated author ORCID identifier.

Publications

Haseena Naz, Fazal Rahim, Rafaqat Hussain, Shoaib Khan, Wajid Rehman, Yousaf Khan, Tariq Aziz, Metab Alharbi
In silico molecular modeling and in vitro biological screening of novel benzimidazole-based piperazine derivatives as potential acetylcholinesterase and butyrylcholinesterase inhibitors. Zeitschrift fur Naturforschung. C, Journal of biosciences (2024)
Sundas Tariq, Fazal Rahim, Hayat Ullah, Maliha Sarfraz, Rafaqat Hussain, Shoaib Khan, Misbah Ullah Khan, Wajid Rehman, Amjad Hussain, Mashooq Ahmad Bhat, Muhammad Kamran Farooqi, Syed Adnan Ali Shah, Naveed Iqbal
Synthesis, In Vitro Biological Evaluation and Molecular Modeling of Benzimidazole-Based Pyrrole/Piperidine Hybrids Derivatives as Potential Anti-Alzheimer Agents. Pharmaceuticals (Basel, Switzerland) 17 (4) (2024)
Shoaib Khan, Rafaqat Hussain, Yousaf Khan, Tayyiaba Iqbal, Saeed Anwar, Tariq Aziz, Metab Alharbi
In vitro enzymatic, in silico ADME and molecular docking based analysis for the identification of novel bis-indole containing triazine-thiazole hybrids derivatives as promising urease inhibitors. Zeitschrift fur Naturforschung. C, Journal of biosciences 79 (7-8) (2024)
Sundas Tariq, Fazal Rahim, Hayat Ullah, Maliha Sarfraz, Rafaqat Hussain, Shoaib Khan, Misbah Ullah Khan, Wajid Rehman, Amjad Hussain, Mashooq Ahmad Bhat, Muhammad Kamran Farooqi, Syed Adnan Ali Shah, Naveed Iqbal
Synthesis, In Vitro Biological Evaluation and Molecular Modeling of Benzimidazole-Based Pyrrole/Piperidine Hybrids Derivatives as Potential Anti-Alzheimer Agents. Pharmaceuticals (Basel, Switzerland) 17 (4) (2024)
Shoaib Khan, Rafaqat Hussain, Yousaf Khan, Tayyiaba Iqbal, Saeed Anwar, Tariq Aziz, Metab Alharbi
In vitro enzymatic, in silico ADME and molecular docking based analysis for the identification of novel bis-indole containing triazine-thiazole hybrids derivatives as promising urease inhibitors. Zeitschrift fur Naturforschung. C, Journal of biosciences (2024)
Shahzad Ahmad Abbasi, Fazal Rahim, Rafaqat Hussain, Wajid Rehman, Shoaib Khan, Muhammad Taha, Tayyiaba Iqbal, Yousaf Khan, Syed Adnan Ali Shah
Synthesis of modified Schiff base appended 1,2,4-triazole hybrids scaffolds: elucidating the in vitro and in silico α-amylase and α-glucosidase inhibitors potential. Zeitschrift fur Naturforschung. C, Journal of biosciences (2024)
Shoaib Khan, Hayat Ullah, Muhammad Taha, Fazal Rahim, Maliha Sarfraz, Rashid Iqbal, Naveed Iqbal, Rafaqat Hussain, Syed Adnan Ali Shah, Khurshid Ayub, Marzough Aziz Albalawi, Mahmoud A Abdelaziz, Fatema Suliman Alatawi, Khalid Mohammed Khan
Synthesis, DFT Studies, Molecular Docking and Biological Activity Evaluation of Thiazole-Sulfonamide Derivatives as Potent Alzheimer's Inhibitors. Molecules (Basel, Switzerland) 28 (2) (2023)
Saeed Anwar, Wajid Rehman, Rafaqat Hussain, Shoaib Khan, A F M Motiur Rahman, Nawaf A Alsaif, Yousaf Khan, Shahid Iqbal, Adeela Naz, Muhammad Ali Hashmi
Investigation of Novel Benzoxazole-Oxadiazole Derivatives as Effective Anti-Alzheimer's Agents: In Vitro and In Silico Approaches. Pharmaceuticals (Basel, Switzerland) 16 (7) (2023)
Rafaqat Hussain, Shoaib Khan, Hayat Ullah, Farhan Ali, Yousaf Khan, Asma Sardar, Rashid Iqbal, Farid Shokry Ataya, Nasser M El-Sabbagh, Gaber El-Saber Batiha
Benzimidazole-Based Schiff Base Hybrid Scaffolds: A Promising Approach to Develop Multi-Target Drugs for Alzheimer's Disease. Pharmaceuticals (Basel, Switzerland) 16 (9) (2023)
Yousaf Khan, Shoaib Khan, Rafaqat Hussain, Wajid Rehman, Aneela Maalik, Urooba Gulshan, Mohamed W Attwa, Hany W Darwish, Hazem A Ghabbour, Nawab Ali
Identification of Indazole-Based Thiadiazole-Bearing Thiazolidinone Hybrid Derivatives: Theoretical and Computational Approaches to Develop Promising Anti-Alzheimer's Candidates. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Rafaqat Hussain, Fazal Rahim, Hayat Ullah, Shoaib Khan, Maliha Sarfraz, Rashid Iqbal, Faiza Suleman, Mohammad Khalid Al-Sadoon
Design, Synthesis, In Vitro Biological Evaluation and In Silico Molecular Docking Study of Benzimidazole-Based Oxazole Analogues: A Promising Acetylcholinesterase and Butyrylcholinesterase Inhibitors. Molecules (Basel, Switzerland) 28 (20) (2023)
Yousaf Khan, Shoaib Khan, Rafaqat Hussain, Wajid Rehman, Aneela Maalik, Urooba Gulshan, Mohamed W Attwa, Hany W Darwish, Hazem A Ghabbour, Nawab Ali
Identification of Indazole-Based Thiadiazole-Bearing Thiazolidinone Hybrid Derivatives: Theoretical and Computational Approaches to Develop Promising Anti-Alzheimer's Candidates. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Yousaf Khan, Shoaib Khan, Rafaqat Hussain, Aneela Maalik, Wajid Rehman, Mohamed W Attwa, Rafia Masood, Hany W Darwish, Hazem A Ghabbour
The Synthesis, In Vitro Bio-Evaluation, and In Silico Molecular Docking Studies of Pyrazoline-Thiazole Hybrid Analogues as Promising Anti-α-Glucosidase and Anti-Urease Agents. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Shoaib Khan, Hayat Ullah, Muhammad Taha, Fazal Rahim, Maliha Sarfraz, Rashid Iqbal, Naveed Iqbal, Rafaqat Hussain, Syed Adnan Ali Shah, Khurshid Ayub, Marzough Aziz Albalawi, Mahmoud A Abdelaziz, Fatema Suliman Alatawi, Khalid Mohammed Khan
Synthesis, DFT Studies, Molecular Docking and Biological Activity Evaluation of Thiazole-Sulfonamide Derivatives as Potent Alzheimer's Inhibitors. Molecules (Basel, Switzerland) 28 (2) (2023)
Yousaf Khan, Shoaib Khan, Rafaqat Hussain, Aneela Maalik, Wajid Rehman, Mohamed W Attwa, Rafia Masood, Hany W Darwish, Hazem A Ghabbour
The Synthesis, In Vitro Bio-Evaluation, and In Silico Molecular Docking Studies of Pyrazoline-Thiazole Hybrid Analogues as Promising Anti-α-Glucosidase and Anti-Urease Agents. Pharmaceuticals (Basel, Switzerland) 16 (12) (2023)
Shoaib Khan, Hayat Ullah, Muhammad Taha, Fazal Rahim, Maliha Sarfraz, Rashid Iqbal, Naveed Iqbal, Rafaqat Hussain, Syed Adnan Ali Shah, Khurshid Ayub, Marzough Aziz Albalawi, Mahmoud A Abdelaziz, Fatema Suliman Alatawi, Khalid Mohammed Khan
Synthesis, DFT Studies, Molecular Docking and Biological Activity Evaluation of Thiazole-Sulfonamide Derivatives as Potent Alzheimer's Inhibitors. Molecules (Basel, Switzerland) 28 (2) (2023)
Rafaqat Hussain, Wajid Rehman, Shoaib Khan, Aneela Maalik, Mohamed Hefnawy, Ashwag S Alanazi, Yousaf Khan, Liaqat Rasheed
Imidazopyridine-Based Thiazole Derivatives as Potential Antidiabetic Agents: Synthesis, In Vitro Bioactivity, and In Silico Molecular Modeling Approach. Pharmaceuticals (Basel, Switzerland) 16 (9) (2023)
Shoaib Khan, Shahid Iqbal, Fazal Rahim, Mazloom Shah, Rafaqat Hussain, Hamad Alrbyawi, Wajid Rehman, Ayed A Dera, Liaqat Rasheed, H H Somaily, Rami Adel Pashameah, Eman Alzahrani, Abd-ElAziem Farouk
New Biologically Hybrid Pharmacophore Thiazolidinone-Based Indole Derivatives: Synthesis, In Vitro Αlpha-Amylase and Αlpha-Glucosidase Along with Molecular Docking Investigations. Molecules (Basel, Switzerland) 27 (19) (2022)
Fazal Rahim, Hayat Ullah, Muhammad Taha, Rafaqat Hussain, Maliha Sarfraz, Rashid Iqbal, Naveed Iqbal, Shoaib Khan, Syed Adnan Ali Shah, Marzough Aziz Albalawi, Mahmoud A Abdelaziz, Fatema Suliman Alatawi, Abdulrahman Alasmari, Mohamed I Sakran, Nahla S Zidan, Ibrahim Jafri, Khalid Mohammed Khan
Synthesis of New Triazole-Based Thiosemicarbazone Derivatives as Anti-Alzheimer's Disease Candidates: Evidence-Based In Vitro Study. Molecules (Basel, Switzerland) 28 (1) (2022)
Sundas Mumtaz, Shahid Iqbal, Mazloom Shah, Rafaqat Hussain, Fazal Rahim, Wajid Rehman, Shoaib Khan, Obaid-Ur-Rahman Abid, Liaqat Rasheed, Ayed A Dera, Hanan A Al-Ghulikah, Sana Kehili, Eslam B Elkaeed, Hamad Alrbyawi, Mohammed Issa Alahmdi
New Triazinoindole Bearing Benzimidazole/Benzoxazole Hybrids Analogs as Potent Inhibitors of Urease: Synthesis, In Vitro Analysis and Molecular Docking Studies. Molecules (Basel, Switzerland) 27 (19) (2022)
Rafaqat Hussain, Shahid Iqbal, Mazloom Shah, Wajid Rehman, Shoaib Khan, Liaqat Rasheed, Fazal Rahim, Ayed A Dera, Sana Kehili, Eslam B Elkaeed, Nasser S Awwad, Majed A Bajaber, Mohammed Issa Alahmdi, Hamad Alrbyawi, Hashem O Alsaab
Synthesis of Novel Benzimidazole-Based Thiazole Derivatives as Multipotent Inhibitors of α-Amylase and α-Glucosidase: In Vitro Evaluation along with Molecular Docking Study. Molecules (Basel, Switzerland) 27 (19) (2022)
Fazal Rahim, Hayat Ullah, Muhammad Taha, Rafaqat Hussain, Maliha Sarfraz, Rashid Iqbal, Naveed Iqbal, Shoaib Khan, Syed Adnan Ali Shah, Marzough Aziz Albalawi, Mahmoud A Abdelaziz, Fatema Suliman Alatawi, Abdulrahman Alasmari, Mohamed I Sakran, Nahla S Zidan, Ibrahim Jafri, Khalid Mohammed Khan
Synthesis of New Triazole-Based Thiosemicarbazone Derivatives as Anti-Alzheimer's Disease Candidates: Evidence-Based In Vitro Study. Molecules (Basel, Switzerland) 28 (1) (2022)
Shoaib Khan, Shahid Iqbal, Muhammad Taha, Fazal Rahim, Mazloom Shah, Hayat Ullah, Ali Bahadur, Hamad Alrbyawi, Ayed A Dera, Mohammed Issa Alahmdi, Rami Adel Pashameah, Eman Alzahrani, Abd-ElAziem Farouk
Synthesis, In Vitro Biological Evaluation and In Silico Molecular Docking Studies of Indole Based Thiadiazole Derivatives as Dual Inhibitor of Acetylcholinesterase and Butyrylchloinesterase. Molecules (Basel, Switzerland) 27 (21) (2022)
Fazal Rahim, Hayat Ullah, Muhammad Taha, Rafaqat Hussain, Maliha Sarfraz, Rashid Iqbal, Naveed Iqbal, Shoaib Khan, Syed Adnan Ali Shah, Marzough Aziz Albalawi, Mahmoud A Abdelaziz, Fatema Suliman Alatawi, Abdulrahman Alasmari, Mohamed I Sakran, Nahla S Zidan, Ibrahim Jafri, Khalid Mohammed Khan
Synthesis of New Triazole-Based Thiosemicarbazone Derivatives as Anti-Alzheimer's Disease Candidates: Evidence-Based In Vitro Study. Molecules (Basel, Switzerland) 28 (1) (2022)
Fazal Rahim, Hayat Ullah, Muhammad Taha, Rafaqat Hussain, Maliha Sarfraz, Rashid Iqbal, Naveed Iqbal, Shoaib Khan, Syed Adnan Ali Shah, Marzough Aziz Albalawi, Mahmoud A Abdelaziz, Fatema Suliman Alatawi, Abdulrahman Alasmari, Mohamed I Sakran, Nahla S Zidan, Ibrahim Jafri, Khalid Mohammed Khan
Synthesis of New Triazole-Based Thiosemicarbazone Derivatives as Anti-Alzheimer's Disease Candidates: Evidence-Based In Vitro Study. Molecules (Basel, Switzerland) 28 (1) (2022)
Hayat Ullah, Shoaib Khan, Fazal Rahim, Muhammad Taha, Rashid Iqbal, Maliha Sarfraz, Syed Adnan Ali Shah, Muhammad Sajid, Mohamed F Awad, Awatif Omran, Marzough Aziz Albalawi, Mahmoud A Abdelaziz, Azza Al Areefy, Ibrahim Jafri
Benzimidazole Bearing Thiosemicarbazone Derivatives Act as Potent α-Amylase and α-Glucosidase Inhibitors; Synthesis, Bioactivity Screening and Molecular Docking Study. Molecules (Basel, Switzerland) 27 (20) (2022)